These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12413360)

  • 21. Chronic hepatitis B--new goals, new treatment.
    Lai CL; Yuen MF
    N Engl J Med; 2008 Dec; 359(23):2488-91. PubMed ID: 19052131
    [No Abstract]   [Full Text] [Related]  

  • 22. What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?
    Simsek H; Shorbagi A; Balaban Y; Tatar G
    J Hepatol; 2008 Sep; 49(3):464-5. PubMed ID: 18644652
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current knowledge on chronic hepatitis B therapy].
    Zoulim F; Werle B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B143-51. PubMed ID: 11449155
    [No Abstract]   [Full Text] [Related]  

  • 24. Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.
    Marcellin P; Asselah T
    J Hepatol; 2005 Dec; 43(6):920-3. PubMed ID: 16246449
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lamivudine, adefovir dipivoxil].
    Miyajima I; Sata M
    Nihon Rinsho; 2011 May; 69 Suppl 4():492-7. PubMed ID: 22096967
    [No Abstract]   [Full Text] [Related]  

  • 26. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
    Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R
    Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New nucleoside analogues for chronic hepatitis B.
    Schalm SW; Wolters LM; van Nunen AB; Niesters HG; de Man RA
    Acta Gastroenterol Belg; 2000; 63(2):191-3. PubMed ID: 10925461
    [No Abstract]   [Full Text] [Related]  

  • 28. A different look at the management of chronic hepatitis B in a resource-constrained country.
    Jia J
    J Viral Hepat; 2013 Apr; 20 Suppl 1():1. PubMed ID: 23458517
    [No Abstract]   [Full Text] [Related]  

  • 29. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
    Gamucci T
    Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
    [No Abstract]   [Full Text] [Related]  

  • 30. Update on the management of chronic hepatitis B.
    Davis GL
    Rev Gastroenterol Disord; 2002; 2(3):106-15. PubMed ID: 12227214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
    Mohamadnejad M
    Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389
    [No Abstract]   [Full Text] [Related]  

  • 32. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: the example of clinical studies].
    Giannessi PG
    Suppl Tumori; 2004; 3(4):S73-4. PubMed ID: 15206218
    [No Abstract]   [Full Text] [Related]  

  • 33. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of adefovir treatment in the lamivudine-resistant chronic hepatitis B patients].
    Chen CY; Tu XL; Cheng QH; Dai Y
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):942-3. PubMed ID: 21205485
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B genotypes and response to adefovir treatment in patients with HBV chronic infection.
    Scotto G; Fazio V
    J Infect; 2010 May; 60(5):399-401. PubMed ID: 20226208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer].
    Chen LR
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):218-21. PubMed ID: 20654118
    [No Abstract]   [Full Text] [Related]  

  • 37. Time to remove the subspecialty blinders: breast cancer does not exist in isolation.
    Giordano SH; Hortobagyi GN
    J Natl Cancer Inst; 2008 Feb; 100(4):230-1. PubMed ID: 18270334
    [No Abstract]   [Full Text] [Related]  

  • 38. The curative efficiency of tenofovir for patients with chronic hepatitis B after failure of nucleoside/nucleotide analogues.
    Chen EQ; Tang H
    Hepatology; 2010 Aug; 52(2):802. PubMed ID: 20683978
    [No Abstract]   [Full Text] [Related]  

  • 39. NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer.
    Mamounas EP; Lembersky B; Jeong JH; Cronin W; Harkins B; Geyer C; Wickerham DL; Paik S; Costantino J; Wolmark N
    Clin Breast Cancer; 2006 Dec; 7(5):416-21. PubMed ID: 17239269
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral therapy for treatment-naïve hepatitis B virus patients.
    Lau DT; Membreno FE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):581-99, ix-x. PubMed ID: 15324945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.